JPRN-UMIN000007842已完成1 期
A phase I/II study of concurrent chemoradiotherapy (RT-DeVIC) for newly-diagnosed, localized nasal NK/T-cell lymphoma (JCOG0211-DI) - A phase I/II study of concurrent chemoradiotherapy (RT-DeVIC) for newly-diagnosed, localized nasal NK/T-cell lymphoma (JCOG0211-DI)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 33 人开始时间: 2012年4月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 69years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Clinical symptoms of Central nervous system involvement 2) Uncontrollable diabetes mellitus 3) Uncontrollable hypertension 4) History of myocardial infarction or angina, and/or cardiomyopathy, and/or arrhythmia treated with antiarrhythmic 5) Positive test for HBs antigen 6) Positive test for HIV antibody 7) Interstitial pneumonia, pulmonary fibrosis or severe pulmonary emphysema 8) Severe infection 9) Liver cirrhosis 10) Other active malignancies 11) Pregnant, possible pregnant, or breastfeeding woman 12) Use of major tranquilizer, antidepressant, or antimanic 13) Severe psychosis 14) Patients or their families, and/or attending physicians hoping hematopoietic stem cell transplantation after obtained responses by RT-DeVIC
研究者
相似试验
撤回
不适用
A Phase II Study of concurrent chemo-radiotherapy with Gemcitabine followed by chemotherapy with Gemcitabine and Cisplatin for unresectable localized perihilar cholangiocarcinomaNeoplasmsKCT0003478CC Hospital27
已完成
2 期
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)ocally Advanced Uterine Cervical CarcinomaJPRN-UMIN000025688Kitasato Gynecologic Radiatoin Oncology Group (KGROG)45
已完成
2 期
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
已完成
2 期
phase II trial of concurrent chemoradiotherapy (CCRT) with docetaxel + cisplatin + cetuximab for locally advanced squamous cell carcinoma of the head and neckadvanced squamous cell carcinoma of the head and neckJPRN-UMIN000013858Department of Biology and Function in the Head and Neck, Yokohama City University Graduate School of Medicine30
已完成
3 期
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)anal canal canerJPRN-UMIN000003237Japan Clinical Oncology Group(JCOG)71